Whipplewood Advisors, LLC Charles River Laboratories International, Inc. Transaction History
Whipplewood Advisors, LLC
- $176 Billion
- Q4 2024
A detailed history of Whipplewood Advisors, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Whipplewood Advisors, LLC holds 26 shares of CRL stock, worth $4,241. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26Holding current value
$4,241% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CRL
# of Institutions
692Shares Held
51.7MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$995 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$830 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$610 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$347 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$316 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.3B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...